VRTX VERTEX PHARM INC

Ownership history in American Trust  ·  5 quarters on record

This page tracks every 13F SEC filing in which American Trust reported a position in VERTEX PHARM INC (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.16% (2025 Q1)
Avg. % of fund
0.07%
First filed
2024 Q3
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 1,322 +11 +0.8% 0.04% $518K $391.64
2025 Q2 ADDED 1,311 +9 +0.7% 0.05% $584K $445.20
2025 Q1 REDUCED 1,302 -201 -13.4% 0.16% $631K $484.82
2024 Q4 ADDED 1,503 +40 +2.7% 0.05% $605K $402.70
2024 Q3 INITIATED 1,463 0.06% $680K $465.08
% of Fund (quarterly)    VRTX price (monthly, adj. close)
← Back to American Trust Holdings